title: Natural phenylalanine hydroxylase variants that confer a mild phenotype affect the enzyme's conformational stability and oligomerization equilibrium.
abstract: Hyperphenylalaninemias are genetic diseases prevalently caused by mutations in the phenylalanine hydroxylase (PAH) gene. The wild-type PAH enzyme is a homotetramer regulated by its substrate, cofactor and phosphorylation. We reproduced a full-length wild-type protein and seven natural full-length PAH variants, p.I65M, p.N223Y, p.R297L, p.F382L, p.K398N, p.A403V, and p.Q419R, and analyzed their biochemical and biophysical behavior. All mutants exhibited reduced enzymatic activity, namely from 38% to 69% of wild-type activity. Biophysical characterization was performed by size-exclusion chromatography, light scattering and circular dichroism. In the purified wild-type PAH, we identified the monomer in equilibrium with the dimer and tetramer. In most mutants, the equilibrium shifted toward the dimer and most tended to form aggregates. All PAH variants displayed different biophysical behaviors due to loss of secondary structure and thermal destabilization. Specifically, p.F382L was highly unstable at physiological temperature. Moreover, using confocal microscopy with the number and brightness technique, we studied the effect of BH4 addition directly in living human cells expressing wild-type PAH or p.A403V, a mild mutant associated with BH4 responsiveness in vivo. Our results demonstrate that BH4 addition promotes re-establishment of the oligomerization equilibrium, thus indicating that the dimer-to-tetramer shift in pA403V plays a key role in BH4 responsiveness. In conclusion, we show that the oligomerization process and conformational stability are altered by mutations that could affect the physiological behavior of the enzyme. This endorses the hypothesis that oligomerization and folding defects of PAH variants are the most common causes of HPAs, particularly as regards mild human phenotypes.
authors.affiliation: CEINGE-Biotecnologie Avanzate Scarl, Naples, Italy.
authors.forename: Monica
authors.initials: M
authors.lastname: Cerreto
authors.forename: Paola
authors.initials: P
authors.lastname: Cavaliere
authors.forename: Carla
authors.initials: C
authors.lastname: Carluccio
authors.forename: Felice
authors.initials: F
authors.lastname: Amato
authors.forename: Adriana
authors.initials: A
authors.lastname: Zagari
authors.forename: Aurora
authors.initials: A
authors.lastname: Daniele
authors.forename: Francesco
authors.initials: F
authors.lastname: Salvatore
mesh_terms: D001708:Biopterins / Q000031:analogs & derivatives / Q000494:pharmacology; D002942:Circular Dichroism; D004795:Enzyme Stability; D006367:HeLa Cells; D006801:Humans; D015151:Immunoblotting; D016297:Mutagenesis, Site-Directed; D009154:Mutation / Q000235:genetics*; D010641:Phenotype; D010651:Phenylalanine Hydroxylase / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D010661:Phenylketonurias / Q000473:pathology*; D011487:Protein Conformation; D017510:Protein Folding; D055503:Protein Multimerization
chemical_list: D001708:Biopterins; D010651:Phenylalanine Hydroxylase; C003402:sapropterin